Why We Walk To End Alzheimer’s: IMA Clinical Research

The Alzheimer's Association Greater New Jersey Chapter is spotlighting people and organizations who are making a difference in the fight to end Alzheimer's and all other dementia, by participating in the upcoming 2022 Walk To End Alzheimer’s (WTEA) - the world’s largest event to raise awareness and funds for Alzheimer’s care, support and research.

Today we say thank you to IMA Clinical Research and Mark Weinberger, PhD, MPH, President and CEO, for joining the fight to end Alzheimer’s and all other forms of dementia. With a large footprint in the greater metro area, IMA Clinical Research is now an Elite sponsor of three Walk to End Alzheimer’s events. The company is a leading sponsor of the Mercer-Middlesex Walk taking place this year on September 17 at Veterans Park in Hamilton Township and the Essex-Hudson-Union Walk to End Alzheimer's®, on September 24 at South Mountain Recreation in West Orange, NJ. IMA is also the top sponsor of the Bergen-Passaic Walk to End Alzheimer's®, taking place on October 16 at Overpeck Park in Ridgefield Park, NJ. We are grateful for the support of IMA Clinical Research and their commitment to one day realizing a world without Alzheimer’s and all other dementia. IMA’s extraordinary passion and dedication to helping all those affected by the disease has inspired and motivated others to get involved. The funds raised by their effort, and others, helps propel the Association’s mission forward - accelerating global research, driving risk reduction and early detection, and maximizing quality care and support.

"We are thankful for the support of IMA Clinical Research. Our combined efforts are helping to advance the mission and has the potential to impact the lives of everyone affected by Alzheimer's disease, now and in the future. Alzheimer’s Association TrialMatch® connects individuals living with Alzheimer's, caregivers and healthy volunteers to clinical trials that may advance Alzheimer's research. The free, easy-to-use service allows you to see which studies are a good fit for you or a family member. To search for studies, receive email notifications about new opportunities or connect with research teams go to alz.org/trialmatch”, said Casey Snyder, Director of Development, Alzheimer’s Association Greater NJ Chapter.

Dr. Weinberger commented, “We are so proud to partner with the Alzheimer’s Association and serve as an Elite sponsor for these important events focusing on such a pressing public health disease. We all know someone who has been touched by this disorder, and we are firmly committed to the Association’s cause.”

“IMA is currently seeking candidates for an Alzheimer’s prevention study. This study is aimed at adults 55 and older who have no pre-existing symptoms of Alzheimer’s or dementia. To learn more about the study, you can visit our website at www.imaresearch.com or call (888) 852-7656."

More than 6 million Americans are living with Alzheimer's disease, the sixth-leading cause of death in the U.S. and the only disease among the top 10 that cannot be cured, prevented, or even slowed. Additionally, more than 11 million family and friends provide care to people with Alzheimer’s and other dementias in the U.S. In New Jersey alone, there are more than 190,000 people living with the disease and 361,000 caregivers.

Register your team today. Sign up as a Team Captain or register to walk as an individual. Learn more at alz.org/njwalk. To donate, text 2ENDALZ to 51555, or contact us at gnjwalks@alz.org for more information.